Fukumura K, Venables JP, Mayeda A. SPF45/RBM17-dependent splicing and multidrug resistance to cancer chemotherapy.
Mol Cell Oncol 2021;
8:1996318. [PMID:
35419480 PMCID:
PMC8997263 DOI:
10.1080/23723556.2021.1996318]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 10/10/2021] [Accepted: 10/13/2021] [Indexed: 06/14/2023]
Abstract
The early splicing complex A occupies at least eighty nucleotides of intron, in which U2AF covers the polypyrimidine tract. SPF45 (RBM17) functionally substitutes for U2AF on a subset of short introns. Since SPF45 expression confers resistance to various anticancer drugs, SPF45-dependent splicing may play a critical role in multidrug resistance.
Collapse